Derrell Porter

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Derek Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Derrell Porter:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. Director Common Stock 12,800 $14,080 $1.10 04 Jun 2025 Direct
Passage BIO, Inc. Director Director Stock Option (right to buy) 201,857 28 May 2025 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 19,500 04 Jun 2025 Direct

Insider Reports Filed by Derrell Porter

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABOS Acumen Pharmaceuticals, Inc. 04 Jun 2025 2 $0 4 Director 05 Jun 2025, 16:51
PASG Passage BIO, Inc. 28 May 2025 1 $0 4 Director 30 May 2025, 19:29
ABOS Acumen Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:46
PASG Passage BIO, Inc. 21 May 2024 1 $0 4 Director 23 May 2024, 16:51
ABOS Acumen Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:43
PASG Passage BIO, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 16:35
ABOS Acumen Pharmaceuticals, Inc. 04 Jan 2023 1 $0 4 Director 04 Jan 2023, 18:41
ABOS Acumen Pharmaceuticals, Inc. 04 Jan 2023 0 $0 3 Director 04 Jan 2023, 18:39
PASG Passage BIO, Inc. 26 May 2022 1 $0 4 Director 31 May 2022, 16:32
PASG Passage BIO, Inc. 27 May 2021 1 $0 4 Director 28 May 2021, 17:56
PASG Passage BIO, Inc. 27 May 2021 0 $0 3 Director 28 May 2021, 17:53